TC
MDCO

TFS Capital’s Medicines Co MDCO Stock Holding History

TFS Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,181
Closed -$285K – 1174
2015
Q1 		$285K Buy
+10,181
New +$286K 0.03% 706
2014
Q4 		– Sell
-183,363
Closed -$4.09M – 1247
2014
Q3 		$4.09M Buy
183,363
+105,244
+135% +$2.67M 0.35% 49
2014
Q2 		$2.27M Buy
78,119
+59,401
+317% +$1.59M 0.18% 157
2014
Q1 		$532K Sell
18,718
-174,786
-90% -$5.78M 0.04% 702
2013
Q4 		$7.47M Sell
193,504
-33,992
-15% -$1.22M 0.35% 36
2013
Q3 		$7.63M Buy
+227,496
New +$7.25M 0.35% 40

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital's MDCO Position: Q2 2015 in Review

TFS Capital sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 10,181 shares — an estimated $285K sold.

TFS Capital first reported a position in MDCO in Q3 2013 and held it in 6 quarters. The position peaked at $7.63M in Q3 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

  • TFS Capital reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
  • TFS Capital sold 10,181 Medicines Co shares in Q2 2015, an estimated $285K.
  • TFS Capital first reported a position in Medicines Co in Q3 2013 and held it in 6 quarters.
  • TFS Capital's Medicines Co position peaked at $7.63M in Q3 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on TFS Capital's 13F filing for Q2 2015, filed 5 Aug 2015.